The list of additional contributors includes prenatal and early-life exposures, certain medications, endocrine disorders, gut microbiome alterations, and hypothalamic injuries, all of which may impair energy homeostasis and metabolic regulation [3]
Pulsatile dosing means more transient effects, flushing, vivid dreams, the kind of stuff that comes and goes with each injection
Riluzole was US Food and Drug Administration (FDA) approved to treat amyotrophic lateral sclerosis in 1994 and is approved for this indication by multiple regulatory agencies [Canadas Therapeutic Products Directorate (TPD), European Medicines Agency (EMA), Australias Therapeutic Goods Administration (TGA)] [81,82,83]
The FDA is watching the compounding space closely